Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
David Steffin(Baylor College of Medicine), Andras Heczey(Baylor College of Medicine)
Cited by 189
Related Papers
Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma
|Cancer Immunology Research|2020|246
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers
|Research Square|2024|17